Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-001478
Filing Date
2025-01-08
Accepted
2025-01-08 20:33:11
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4196
  Complete submission text file 0001493152-25-001478.txt   5888
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6209 WEDGEWOOD RD BETHESDA MD 20817
Business Address
Shojaei Amir (Reporting) CIK: 0002051427 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 25519837